Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-15-000024
Filing Date
2015-05-07
Accepted
2015-05-07 16:36:28
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gale-20150331x10q.htm 10-Q 820311
2 EXHIBIT 31.1 gale-20150331xex311.htm EX-31.1 8080
3 EXHIBIT 31.2 gale-20150331xex312.htm EX-31.2 8172
4 EXHIBIT 32.1 gale-20150331xex321.htm EX-32.1 6881
11 pipeline4302015.jpg GRAPHIC 320713
  Complete submission text file 0001390478-15-000024.txt   7352372

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gale-20150331.xml EX-101.INS 1040016
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20150331.xsd EX-101.SCH 49789
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20150331_cal.xml EX-101.CAL 58547
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20150331_def.xml EX-101.DEF 190957
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20150331_lab.xml EX-101.LAB 567095
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20150331_pre.xml EX-101.PRE 320207
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 15842350
SIC: 2834 Pharmaceutical Preparations